Milano offers science and innovation, Ema Milano – Eleven universities and seven art academies, with more than 200,000 students, as well as an extensive network of public and private research institutions, create a vibrant environment for research and innovation.
The proximity of the Italian Medicines Agency (AIFA) is a notable advantage. The AIFA is familiar with the regulation governing the sector and collaborates with an extensive network of top researchers and clinicians from academia, public and private research institutes, hospitals and academic societies as well as patients’ associations.
Italy has the second largest pharmaceutical industry in Europe in terms of production volumes and is the world’s largest exporter of medicines per capita. Milan and its metropolitan area account for 60% of Italy’s overall pharmaceutical production. Moreover, streamlined administrative procedures and an entrepreneur-friendly approach make Milan an ideal city in which to invest and create new opportunities.